News | Thrombectomy Devices | January 30, 2025

Penumbra Launches Laser-Cut Hypotube Sheath Designed for Venous Thromboembolism

The Element Vascular Access System, the first laser-cut hypotube sheath is designed for venous thromboembolism and is compatible with Lightning Flash 2.0. 


Penumbra recently launched its Element Vascular Access System, a laser-cut hypotube sheath designed for venous thromboembolism (VTE). The Element Vascular Access System is compatible with Lightning Flash 2.0, a powerful and advanced mechanical thrombectomy system for the removal of venous thrombus and the treatment of pulmonary embolism (PE), effectively completing Penumbra’s VTE platform.

“The flexibility and torqueability of the Lightning Flash 2.0 catheter paired with the foundational support of the Element sheath has allowed us excellent angiographic and clinical success,” said Raj Kakarla, M.D., interventional radiologist at Javon Bea Hospital in Rockford, Illinois. “Penumbra’s continuous advancements provide a comprehensive portfolio for physicians to treat a wider range of patients and improve patient outcomes.”

Innovative Valve Technology 

Element features the HemoLock Valve System, designed to ensure hemostasis through dual-valve engineering. Equipped with a rotating hemostatic valve and a removable cross-cut valve, the system provides physicians with precise control during procedures.

Advanced Hypotube Engineering 

The Element laser-cut hypotube design is engineered to maintain stepwise support throughout vasculature to enhance performance across challenging anatomies. The atraumatic tip design is meticulously crafted to help enable smooth delivery and trackability. The proximal segment is purposefully engineered to deliver foundational support, while optimized polymer transitions help maintain sheath access without the application of proximal hydrophilic coatings.

The Element hypotube is composed of 17 French MaxID technology, tailor-made for use in conjunction with the Lightning Flash 2.0, CATTM16 catheter. This technology enables in-case visualization via hand injection around the CAT16 and provides sufficient space to torque CAT16.

Additional information about Penumbra’s products is available at hwww.penumbrainc.com/providers.  


Related Content

News | Thrombectomy Devices

Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston ...

Home January 19, 2026
Home
News | Thrombectomy Devices

Dec. 10, 2025 — Medtronic plc has announced the first commercial use of the Liberant thrombectomy system (Liberant) ...

Home January 07, 2026
Home
News | Thrombectomy Devices

Dec. 16, 2025 — A new study, published in the American Journal of Cardiology, found that the use of Computer Assisted ...

Home December 23, 2025
Home
News | Thrombectomy Devices

Nov. 3, 2025 — Penumbra, Inc. has announced additional results of the STORM-PE randomized controlled trial (RCT), which ...

Home November 07, 2025
Home
News | Thrombectomy Devices

Oct. 27, 2025 – Penumbra, Inc. has announced the results of the STORM-PE randomized controlled trial (RCT), which found ...

Home October 27, 2025
Home
News | Thrombectomy Devices

Sept. 2, 2025 — Imperative Care, Inc. has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its ...

Home September 02, 2025
Home
News | Thrombectomy Devices

June 16, 2025 – Penumbra, Inc. recently announced the completion of enrollment in the STORM-PE clinical trial. This ...

Home June 16, 2025
Home
News | Thrombectomy Devices

March 24, 2025 — Imperative Care, Inc. recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance of ...

Home March 24, 2025
Home
News | Thrombectomy Devices

Nov. 5, 2024 —Penumbra, Inc. recently announced new data that demonstrate patients with intermediate-risk pulmonary ...

Home November 07, 2024
Home
News | Thrombectomy Devices

Sept. 24, 2024 — Thrombolytic Science, LLC (TSI) has announced that the U.S. Food and Drug Administration (FDA) has ...

Home September 24, 2024
Home
Subscribe Now